Track what's actually being bought

See what Congress & insiders are buying.

When members of Congress trade stocks, when CEOs buy their own company, when companies win government contracts — we collect those public filings and turn them into tested trading signals. And unlike most sites, we show the honest scorecard: every test, including the ones that didn't work, with every number traceable to its source.

Free strategy of the week · Jul 13

Buy the Trial Flop LONG

Congress purchase on a ticker that had a Phase 3 trial TERMINATED in the trailing 60 days. Political-layer mirror of insiderBuyAfterTrialFailure. Mean-reversion bet on the post-failure dislocation — congressional buyers may have visibility into the remaining-pipeline value via committee briefings or sector contacts that the market doesn't price in immediately.

Beats market by
+4.65%
over 90 days, vs sector index
Win rate
71%
87 backtested trades

Hypothetical backtested result — not a recommendation. Past performance does not predict future results.

Our default: use its default sell rule — beat the market by +15.25% across 63 past trades.
Show all 25 sell rules we tested — including the ones that did worse
+50% take-profit +15.25% 63 trades
Bracket +50% / -25% +15.10% 63 trades
Hold 365 days +13.18% 55 trades
-20% stop-loss +12.15% 55 trades
+35% take-profit +11.78% 67 trades
Breakeven (arm at +15%) +11.26% 56 trades
-12% stop-loss +8.98% 59 trades
Breakeven (arm at +8%) +8.73% 64 trades
+20% take-profit +7.53% 75 trades
15% trailing stop +7.38% 74 trades
Bracket +30% / -15% +6.70% 73 trades
Breakeven (arm at +5%) +5.95% 69 trades
Hold 180 days +5.80% 82 trades
ATR-3 volatility stop +5.02% 87 trades
Bracket +20% / -10% +4.82% 78 trades
8% trailing stop +4.80% 87 trades
Hold 90 days +4.65% 87 trades
-8% stop-loss +4.31% 60 trades
200-day MA cross +2.45% 76 trades
50-day MA cross +1.94% 87 trades
Hold 30 days +1.37% 90 trades
100-day MA cross +0.81% 90 trades
ATR-2 volatility stop +0.62% 87 trades
10-day MA cross +0.21% 92 trades
20-day MA cross -0.38% 90 trades
Recent picks — tap any ticker for the underlying data
Share this strategy
𝕏 in R f @
Sign in to share with your referral code attached

Get the weekly strategy by email

One short Monday email with the free strategy of the week + a few notable signals. No spam.

We'll only use your email for this newsletter. Unsubscribe anytime. See our Privacy Policy.

Unlock the full library

77 backtested strategies · live signal alerts · watchlists · custom backtests. Early-access pricing, locked in for life — $25 $15/mo or $250 $150/yr.

Subscription automatically renews at $15/month (or $150/year) until you cancel. Cancel anytime.